THERAPY PROTOCOL ACTIVATION TRIGGERED BASED ON INITIAL COUPLING
First Claim
1. A device for treating sleep apnea, and for cooperating with an adhesive patch to convey power from a location external to a subject to an implant location within the subject, the device comprising:
- a housing configured for selective mounting on the adhesive patch; and
at least one processor within the housing, wherein the at least one processor is configured to;
activate when the housing is mounted on the adhesive patch, wherein activation enables the implant to modulate a hypoglossal nerve and thereby cause contraction of a genioglossus muscle;
delay, for a predetermined amount of time following activation of the at least one processor, generation of modulation signals to thereby delay at least one contraction of a genioglossus muscle until after the subject has had opportunity to fall asleep.
2 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure is directed to a control unit for cooperating with an adhesive patch to convey power from a location external to a subject to a location within the subject. The control unit may include a housing configured for selective mounting on the adhesive patch and may further include at least one processor within the housing. The at least one processor may be configured to activate when the housing is mounted on the adhesive patch and to delay, for a predetermined amount of time following activation of the at least one processor, generation of therapeutic control signals for modulating at least one nerve in the subject'"'"'s body.
25 Citations
21 Claims
-
1. A device for treating sleep apnea, and for cooperating with an adhesive patch to convey power from a location external to a subject to an implant location within the subject, the device comprising:
-
a housing configured for selective mounting on the adhesive patch; and at least one processor within the housing, wherein the at least one processor is configured to; activate when the housing is mounted on the adhesive patch, wherein activation enables the implant to modulate a hypoglossal nerve and thereby cause contraction of a genioglossus muscle; delay, for a predetermined amount of time following activation of the at least one processor, generation of modulation signals to thereby delay at least one contraction of a genioglossus muscle until after the subject has had opportunity to fall asleep. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A device for treatment of sleep disordered breathing, the device comprising:
-
a patch configured for temporary affixation on a region including at least one of an underside of a chin, a neck, and a head of a subject; and a control unit, wherein the control unit includes; a housing configured for selectively mounting on the patch; and at least one processor, wherein the at least one processor is configured to; activate when the housing is mounted on the patch; and delay, for a predetermined amount of time following activation of the at least one processor, generation of therapeutic control signals for modulation of at least one nerve of the subject'"'"'s body. - View Dependent Claims (9, 10, 11, 12, 13, 14, 15, 16)
-
-
17. A method of activating a therapy protocol for delivery of power to an implant, the method comprising:
-
engaging a control unit with an adhesive patch, the control unit comprising a housing and at least one processor within the housing; activating the at least one processor when the housing is mounted on the adhesive patch; enabling the at least one processor to generate therapeutic control signals for modulating at least one nerve in the subject'"'"'s body; and delaying, for a predetermined amount of time following activation of the at least one processor, generation of therapeutic control signals by the at least one processor. - View Dependent Claims (18, 19, 20)
-
-
21. A control unit for cooperating with an adhesive patch to convey power from a location external to a subject to a location within the subject, the control unit comprising:
-
a housing configured for selective mounting on the adhesive patch; and at least one processor within the housing, wherein the at least one processor is configured to; activate when the housing is mounted on the adhesive patch; delay, for a predetermined amount of time following activation of the at least one processor, generation of therapeutic control signals for modulating at least one nerve in the subject'"'"'s body.
-
Specification